Cargando…
Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis
SIMPLE SUMMARY: Successful treatment of hematological malignancies with chimeric antigen receptors T (CAR-T) cells has led to much enthusiasm for the wide clinical usage and development of novel CAR-T therapies. However, it also challenges physicians and investigators to recognize and deal with trea...
Autores principales: | Lei, Wen, Xie, Mixue, Jiang, Qi, Xu, Nengwen, Li, Ping, Liang, Aibin, Young, Ken H., Qian, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345443/ https://www.ncbi.nlm.nih.gov/pubmed/34359816 http://dx.doi.org/10.3390/cancers13153912 |
Ejemplares similares
-
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
por: Yang, Chieh, et al.
Publicado: (2023) -
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies
por: Liang, Yun, et al.
Publicado: (2021) -
Efficacy and safety of chimeric antigen receptor T-cell (CAR-T)
therapy in hematologic malignancies: a living systematic review on comparative
studies
por: Saiz, Luis Carlos, et al.
Publicado: (2023) -
Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021) -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021)